ATE315082T1 - Myeloider koloniestimulierungsfaktor und verwendungen davon - Google Patents

Myeloider koloniestimulierungsfaktor und verwendungen davon

Info

Publication number
ATE315082T1
ATE315082T1 AT01905087T AT01905087T ATE315082T1 AT E315082 T1 ATE315082 T1 AT E315082T1 AT 01905087 T AT01905087 T AT 01905087T AT 01905087 T AT01905087 T AT 01905087T AT E315082 T1 ATE315082 T1 AT E315082T1
Authority
AT
Austria
Prior art keywords
stimulating factor
colony stimulating
myeloid colony
csf5
hyaluronidase
Prior art date
Application number
AT01905087T
Other languages
English (en)
Inventor
Gregory I Frost
Per Borgstrom
Original Assignee
Sidney Kimmel Cancer Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidney Kimmel Cancer Ct filed Critical Sidney Kimmel Cancer Ct
Application granted granted Critical
Publication of ATE315082T1 publication Critical patent/ATE315082T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01905087T 2000-01-25 2001-01-25 Myeloider koloniestimulierungsfaktor und verwendungen davon ATE315082T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17791300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
ATE315082T1 true ATE315082T1 (de) 2006-02-15

Family

ID=22650424

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01905087T ATE315082T1 (de) 2000-01-25 2001-01-25 Myeloider koloniestimulierungsfaktor und verwendungen davon

Country Status (9)

Country Link
EP (1) EP1250422B1 (de)
JP (1) JP2004500079A (de)
AT (1) ATE315082T1 (de)
AU (1) AU784155B2 (de)
CA (1) CA2398539C (de)
DE (1) DE60116466T2 (de)
DK (1) DK1250422T3 (de)
ES (1) ES2259024T3 (de)
WO (1) WO2001055357A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542873A (en) 2003-03-05 2008-07-31 Halozyme Inc Soluble, neutral-active hyaluronidase activity glycoprotein (sHASEGP) that is produced with high yield in a mammalian expression system by introducing nucleic acids that lack a narrow region encoding amino acids in the carboxy terminus of the human PH20 cDNA
KR101454646B1 (ko) * 2012-11-05 2014-10-27 (주)한국비엠아이 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123938A (en) * 1996-10-17 2000-09-26 The Regents Of The University Of California Human urinary hyaluronidase

Also Published As

Publication number Publication date
AU3300401A (en) 2001-08-07
AU784155B2 (en) 2006-02-09
WO2001055357A2 (en) 2001-08-02
ES2259024T3 (es) 2006-09-16
DK1250422T3 (da) 2006-05-29
EP1250422B1 (de) 2006-01-04
CA2398539C (en) 2011-05-31
WO2001055357A3 (en) 2002-03-28
DE60116466D1 (de) 2006-03-30
DE60116466T2 (de) 2006-09-28
EP1250422A2 (de) 2002-10-23
CA2398539A1 (en) 2001-08-02
JP2004500079A (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
DE60140794D1 (de) Von casein abgeleitete peptide und deren anwendung für die therapie
WO2001090129A3 (en) Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
AU2155795A (en) Alphavirus cdna vectors
WO2002086100A3 (en) Expression of core-glycosylated hcv envelope proteins in yeast
IL157504A0 (en) Oncolytic virus therapy
MX9603925A (es) Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas.
WO1996040940A3 (en) A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
PL375113A1 (en) Casein derived peptides and uses thereof in therapy
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ATE315082T1 (de) Myeloider koloniestimulierungsfaktor und verwendungen davon
MD990258A (en) Method of treatment of the acute viral hepatitis B
DE60130775D1 (de) Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
AU2003253894A1 (en) Combination therapies with ftc for the treatment of hepatitis b virus infection
WO2024040030A3 (en) Treating protein misfolding disorders
TW200513258A (en) Auxiliary agent for hepatitis C
ATE386542T1 (de) Mittel zur stimulation des immunsystems
GR1002969B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250422

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee